Genetic variation in IL6 gene and type 2 diabetes: tagging-SNP haplotype analysis in large-scale case–control study and meta-analysis
Open Access
- 27 April 2006
- journal article
- research article
- Published by Oxford University Press (OUP) in Human Molecular Genetics
- Vol. 15 (11), 1914-1920
- https://doi.org/10.1093/hmg/ddl113
Abstract
Interleukin-6 (IL-6, gene symbol IL6) is a proinflammatory cytokine. High circulating IL-6 levels have been associated with insulin resistance and greater risk of type 2 diabetes. Using a linkage disequilibrium (LD)-based approach, we sought to investigate the associations of the common polymorphisms comprehensively defining the genetic variability at the IL6 locus with diabetes risk. We conducted a case–control study of 2691 cases of type 2 diabetes (1692 women and 999 men) and 3237 control subjects (2238 women and 999 men) from the Nurses' Health Study and the Health Professional Follow-up Study. Pairwise LD analysis indicated that all the IL6 polymorphisms (rs2069827, rs1800797, rs1800795, rs1554606, rs2069849, rs2069861 and rs1818879) were in strong LD. We did not find significant associations between IL6 polymorphisms and the risk of type 2 diabetes in women or men, individually or in haplotypes. In addition, none of the IL6 polymorphisms was significantly associated with the plasma levels of IL-6 in the control subjects. Our meta-analysis of 5383 diabetes case and 12 069 controls indicated a null association between the best-studied 5′ promoter polymorphism −174G>C (rs1800795) and diabetes risk. Diversity in adiposity, age and sex could not account for the heterogeneity across different studies. In summary, the data in this study do not support substantial associations between the common polymorphisms in IL6 gene and circulating IL-6 levels and the risk of type 2 diabetes.Keywords
This publication has 34 references indexed in Scilit:
- C-174G Polymorphism in the Promoter of the Interleukin-6 Gene Is Associated With Insulin ResistanceDiabetes Care, 2005
- TNF-?, TGF-?1, IL-10, IL-6, Gene Polymorphisms in Latent Autoimmune Diabetes of Adults (LADA) and Type 2 Diabetes MellitusJournal of Clinical Immunology, 2004
- Significant Association of the Interleukin-6 Gene Polymorphisms C-174G and A-598G with Type 2 DiabetesJournal of Clinical Endocrinology & Metabolism, 2004
- Body Mass Index and C-174G Interleukin-6 Promoter Polymorphism Interact in Predicting Type 2 DiabetesJournal of Clinical Endocrinology & Metabolism, 2004
- Inflammatory Markers and Risk of Developing Type 2 Diabetes in WomenDiabetes, 2004
- Promoter Polymorphisms of the TNF-α (G-308A) and IL-6 (C-174G) Genes Predict the Conversion From Impaired Glucose Tolerance to Type 2 DiabetesDiabetes, 2003
- Inflammatory Cytokines and the Risk to Develop Type 2 DiabetesDiabetes, 2003
- The interleukin-6 (−174) G/C promoter polymorphism is associated with type-2 diabetes mellitus in Native Americans and CaucasiansHuman Genetics, 2003
- C-Reactive Protein, Interleukin 6, and Risk of Developing Type 2 Diabetes MellitusJAMA, 2001
- Omental and Subcutaneous Adipose Tissues of Obese Subjects Release Interleukin-6: Depot Difference and Regulation by GlucocorticoidJournal of Clinical Endocrinology & Metabolism, 1998